1979
DOI: 10.1016/0035-9203(79)90004-x
|View full text |Cite
|
Sign up to set email alerts
|

The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies

Abstract: From October to December 1977, an extensive epizootic occurred in Egypt resulting in abortions and increased mortality in domestic animals, and severe clinical disease with fatalities in man. Rift Valley Fever (RVF) virus was isolated and identified as the causative agent. In humans, acute febrile, encephalitic, ocular and fatal haemorrhagic diseases were documented as resulting from RVF virus infection. A retrospective serological survey indicated RVF was recently introduced into the area. The 1977 epizootic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
197
0
5

Year Published

1980
1980
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 304 publications
(212 citation statements)
references
References 7 publications
0
197
0
5
Order By: Relevance
“…By asking existing infectious agents to do unlikely things one can focus on blocks to transmission between humans. Each infection with Lassa fever virus, Rift Valley Fever virus [13], Chlamydia psittaci, or Rickettsia prowazeki results from an encounter with an infected animal or arthropod. The disease in humans is sometimes severe, and with Lassa fever [14] (as with Ebola virus infection) there can be limited spread to hospital staff following contact with infected blood or tissue fluids.…”
Section: Possible Future Developmentsmentioning
confidence: 99%
“…By asking existing infectious agents to do unlikely things one can focus on blocks to transmission between humans. Each infection with Lassa fever virus, Rift Valley Fever virus [13], Chlamydia psittaci, or Rickettsia prowazeki results from an encounter with an infected animal or arthropod. The disease in humans is sometimes severe, and with Lassa fever [14] (as with Ebola virus infection) there can be limited spread to hospital staff following contact with infected blood or tissue fluids.…”
Section: Possible Future Developmentsmentioning
confidence: 99%
“…In the plaque reduction neutralization test (PRNT) sera were serially diluted in fourfold steps from 1/10 and added to previously titrated Zagazig (ZH) 501 strain of RVFV (Meegan, 1979). The mixtures (containing 40-50 PFU) were incubated for 60 min at 37°C and then seeded into tissue culture plates containing 2-4 dayold confluent Vero cell monolayers.…”
Section: Serological Specimensmentioning
confidence: 99%
“…Since then, RVFPV has spread to many African countries [10,11], Saudi Arabia [7,12] and Yemen outside Africa [11]. …”
Section: Introductionmentioning
confidence: 99%